The unit has been rebranded to reinforce its focus on the medical device sector. Premier acquired and renamed the medical device contract research organisation in 2007. Now, to emphasise its medical device focus, the unit has reverted to its pre-acquisition name, D-Target.
A compound annual growth rate of 13.9 per cent from 2009 to 2014 is predicted for the medical device service industry, said Markets & Markets. To crack this sector CROs need skills distinct from those used to service the biopharm industry.
Located in more than 30 countries worldwide, D-Target has primary offices in Yverdon, Switzerland and Boston, Massachusetts, US.